Recall Enforment Report D-0319-2019

Recall Details

Drug Recall Enforcement Report Class II voluntary initiated by GE Healthcare Inc. Life Sciences, originally initiated on 10-29-2018 for the product Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20. The product was recalled due to defective container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.. The product was distributed in Tn and the recall is currently terminated.

Field Name Field Value
Event ID 81691 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-0319-2019 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern TN What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.
Reason For Recall Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles. What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 1092 cartons Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 12-26-2018
Recall Initiation Date 10-29-2018 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Termination Date 10-30-2023 What is the Date Terminated?
The date that FDA terminated the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm GE Healthcare Inc. Life Sciences
Code Info Lot #: 14301544, Exp 21Sep21 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 0407-1401-52; 0407-1411-10; 0407-1411-20; 0407-1412-10; 0407-1412-20; 0407-1412-50; 0407-1412-29; 0407-1412-30; 0407-1412-60; 0407-1412-33; 0407-1412-27; 0407-1412-49; 0407-1412-34; 0407-1412-28; 0407-1412-35; 0407-1413-11; 0407-1413-10; 0407-1413-59; 0407-1413-30; 0407-1413-50; 0407-1413-51; 0407-1413-61; 0407-1413-95; 0407-1413-98; 0407-1413-62; 0407-1413-99; 0407-1413-60; 0407-1413-63; 0407-1413-91; 0407-1413-53; 0407-1413-90; 0407-1413-65; 0407-1413-92; 0407-1413-66; 0407-1413-93; 0407-1413-96; 0407-1413-69; 0407-1414-21; 0407-1414-50; 0407-1414-51; 0407-1414-52; 0407-1414-89; 0407-1414-20; 0407-1414-90; 0407-1414-22; 0407-1414-53; 0407-1414-60; 0407-1414-91; 0407-1414-76; 0407-1414-03; 0407-1414-23; 0407-1414-93; 0407-1414-04; 0407-1414-94; 0407-1414-24; 0407-1414-80; 0407-1414-95; 0407-1415-09; 0407-1416-12
Status Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0407-1401Omnipaque IohexolInjection, SolutionIntravascular; IntravenousGe Healthcare Inc.Human Prescription Drug
0407-1411Omnipaque IohexolInjection, SolutionIntrathecal; Oral; RectalGe Healthcare Inc.Human Prescription Drug
0407-1412Omnipaque Ge Healthcare Inc.
0407-1412Omnipaque IohexolInjection, SolutionIntra-articular; Intrathecal; Intravascular; Intravenous; Oral; RectalGe Healthcare Inc.Human Prescription Drug
0407-1413Omnipaque Ge Healthcare Inc.
0407-1413Omnipaque Ge Healthcare Inc.
0407-1413Omnipaque Ge Healthcare Inc.
0407-1413Omnipaque Ge Healthcare
0407-1413Omnipaque IohexolInjection, SolutionIntra-articular; Intrathecal; Intravascular; Intravenous; Oral; RectalGe Healthcare Inc.Human Prescription Drug
0407-1413Omnipaque IohexolInjection, SolutionIntravenousGe HealthcareHuman Prescription Drug
0407-1414Omnipaque Ge Healthcare Inc.
0407-1414Omnipaque Ge Healthcare Inc.
0407-1414Omnipaque Ge Healthcare Inc.
0407-1414Omnipaque Ge Healthcare
0407-1414Omnipaque IohexolInjection, SolutionIntra-articular; Intravascular; Intravenous; OralGe Healthcare Inc.Human Prescription Drug
0407-1414Omnipaque IohexolInjection, SolutionIntravenousGe HealthcareHuman Prescription Drug
0407-1415Omnipaque IohexolSolutionOralGe Healthcare Inc.Human Prescription Drug
0407-1416Omnipaque IohexolSolutionOralGe Healthcare Inc.Human Prescription Drug